Barbara Klencke T Scan Therapeutics, Inc. (TCRX) insider trading activity
Barbara Klencke is of TScan Therapeutics, Inc.. Currently has a direct ownership of 30,000 shares of TCRX, which is worth approximately $171,300. The most recent transaction as insider was on Dec 14, 2023, when has been sold 5,000 shares (Voting Common Stock) at a price of $5.08 per share, resulting in proceeds of $25,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
30K
0%
3M change
n/a
12M change
Total Value Held
$171,300
Barbara Klencke Transaction History
Also insider at
BK
Barbara Klencke
Solana Beach, CA